Literature DB >> 11502551

Ca(2+) influx and cAMP elevation overcame botulinum toxin A but not tetanus toxin inhibition of insulin exocytosis.

X Huang1, Y H Kang, E A Pasyk, L Sheu, M B Wheeler, W S Trimble, A Salapatek, H Y Gaisano.   

Abstract

Previous reports showed that cleavage of vesicle-associated membrane protein-2 (VAMP-2) and synaptosomal-associated protein of 25 kDa (SNAP-25) by clostridial neurotoxins in permeabilized insulin-secreting beta-cells inhibited Ca(2+)-evoked insulin secretion. In these reports, the soluble N-ethylmaleimide-sensitive factor attachment protein target receptor proteins might have formed complexes, which preclude full accessibility of the putative sites for neurotoxin cleavage. In this work, VAMP-2 and SNAP-25 were effectively cleaved before they formed toxin-insensitive complexes by transient transfection of insulinoma HIT or INS-1 cells with tetanus toxin (TeTx) or botulinum neurotoxin A (BoNT/A), as shown by immunoblotting and immunofluorescence microscopy. This resulted in an inhibition of Ca(2+) (glucose or KCl)-evoked insulin release proportionate to the transfection efficiency (40-50%) and an accumulation of insulin granules. With the use of patch-clamp capacitance measurements, Ca(2+)-evoked exocytosis by membrane depolarization to -10 mV was abolished by TeTx (6% of control) but only moderately inhibited by BoNT/A (30% of control). Depolarization to 0 mV to maximize Ca(2+) influx partially overcame BoNT/A (50% of control) but not TeTx inhibition. Of note, cAMP activation potentiated Ca(2+)-evoked secretion by 129% in control cells but only 55% in BoNT/A-transfected cells and had negligible effects in TeTx-transfected cells. These results indicate that, whereas VAMP-2 is absolutely necessary for insulin exocytosis, the effects of SNAP-25 depletion on exocytosis, perhaps on insulin granule pool priming or mobilization steps, could be partially reversed by higher levels of Ca(2+) or cAMP potentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502551     DOI: 10.1152/ajpcell.2001.281.3.C740

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  Syntaxin clusters assemble reversibly at sites of secretory granules in live cells.

Authors:  S Barg; M K Knowles; X Chen; M Midorikawa; Wolfhard Almers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

2.  A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.

Authors:  Mark Bajohrs; Colin Rickman; Thomas Binz; Bazbek Davletov
Journal:  EMBO Rep       Date:  2004-11       Impact factor: 8.807

3.  Role of the SNARE protein SNAP23 on cAMP-stimulated renin release in mouse juxtaglomerular cells.

Authors:  Mariela Mendez; Herbert Y Gaisano
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-26

4.  Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell.

Authors:  Samantha K Li; Dan Zhu; Herbert Y Gaisano; Patricia L Brubaker
Journal:  Diabetologia       Date:  2013-12-20       Impact factor: 10.122

5.  Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines.

Authors:  Y Kang; X Huang; E A Pasyk; J Ji; G G Holz; M B Wheeler; R G Tsushima; H Y Gaisano
Journal:  Diabetologia       Date:  2002-02       Impact factor: 10.122

6.  Lipid and cationic polymer based transduction of botulinum holotoxin, or toxin protease alone, extends the target cell range and improves the efficiency of intoxication.

Authors:  Chueh-Ling Kuo; George Oyler; Charles B Shoemaker
Journal:  Toxicon       Date:  2009-10-21       Impact factor: 3.033

7.  Syntaxin-3 Binds and Regulates Both R- and L-Type Calcium Channels in Insulin-Secreting INS-1 832/13 Cells.

Authors:  Li Xie; Subhankar Dolai; Youhou Kang; Tao Liang; Huanli Xie; Tairan Qin; Lu Yang; Liangyi Chen; Herbert Y Gaisano
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.